|
|
|
|
LEADER |
01000caa a22002652c 4500 |
001 |
NLM373682530 |
003 |
DE-627 |
005 |
20250306073747.0 |
007 |
cr uuu---uuuuu |
008 |
240617s2024 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2024.110283
|2 doi
|
028 |
5 |
2 |
|a pubmed25n1244.xml
|
035 |
|
|
|a (DE-627)NLM373682530
|
035 |
|
|
|a (NLM)38880200
|
035 |
|
|
|a (PII)S1521-6616(24)00392-9
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Soul, J
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Tissue gene expression profiles and communication networks inform candidate blood biomarker identification in psoriasis and atopic dermatitis
|
264 |
|
1 |
|c 2024
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 19.07.2024
|
500 |
|
|
|a Date Revised 19.07.2024
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.
|
520 |
|
|
|a Overlapping clinical and pathomechanistic features can complicate the diagnosis and treatment of inflammatory skin diseases, including psoriasis and atopic dermatitis (AD). Spatial transcriptomics allows the identification of disease- and cell-specific molecular signatures that may advance biomarker development and future treatments. This study identified transcriptional signatures in keratinocytes and sub-basal CD4+ and CD8+ T lymphocytes from patients with psoriasis and AD. In silico prediction of ligand:receptor interactions delivered key signalling pathways (interferon, effector T cells, stroma cell and matrix biology, neuronal development, etc.). Targeted validation of selected transcripts, including CCL22, RELB, and JUND, in peripheral blood T cells suggests the chosen approach as a promising tool also in other inflammatory diseases. Psoriasis and AD are characterized by transcriptional dysregulation in T cells and keratinocytes that may be targeted therapeutically. Spatial transcriptomics is a valuable tool in the search for molecular signatures that can be used as biomarkers and/or therapeutic targets
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Atopic dermatitis
|
650 |
|
4 |
|a Bioinformatic
|
650 |
|
4 |
|a Biomarker
|
650 |
|
4 |
|a Inflammation
|
650 |
|
4 |
|a Psoriasis
|
650 |
|
4 |
|a Spatial transcriptomics
|
650 |
|
4 |
|a Treatment
|
650 |
|
7 |
|a Biomarkers
|2 NLM
|
700 |
1 |
|
|a Carlsson, E
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Hofmann, S R
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Russ, S
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Hawkes, J
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Schulze, F
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Sergon, M
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Pablik, J
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Abraham, S
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Hedrich, C M
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 265(2024) vom: 01. Aug., Seite 110283
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnas
|
773 |
1 |
8 |
|g volume:265
|g year:2024
|g day:01
|g month:08
|g pages:110283
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2024.110283
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 265
|j 2024
|b 01
|c 08
|h 110283
|